Skip to main content

Table 2 Type of immediate postpartum contraception initiation during the COVID-19 period (n = 3765)

From: The prevalence of contraceptive use among postpartum women and its associated factors during the early phase of COVID-19 outbreak: a time series study

Variables

COVID-19 period

(n = 1821)

Historical cohort

(n = 1944)

p-value*

 

n (%)

n (%)

 

Female sterilization

331 (17.03)

326 (17.90)

0.24

Contraceptive implant

40 (2.06)

41 (2.25)

 

DMPAa

6 (0.31)

1 (0.05)

 

Copper IUDb

2 (0.10)

0

 

No contraception

1565 (80.50)

1453 (79.79)

 
  1. *Fisher’s exact test
  2. aDepot medroxyprogesterone acetate
  3. bCopper intrauterine device
Back to article page

Reproductive Health

ISSN: 1742-4755